Reaction
Instillation Site Pain reporting signals
As of the last recalculation, Instillation Site Pain appears in 2,471 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is LIFITEGRAST (PRR 1,374.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lifitegrast | 1,283 | 1,374.7 | 1,492.6 |
| Carboxymethylcellulose Sodium | 45 | 41.1 | 41.3 |
| Cyclosporine | 336 | 29.3 | 29.4 |
| Latanoprost | 69 | 11.9 | 11.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 9 | 9.6 | 9.6 |
| Timolol Maleate | 11 | 9.4 | 9.4 |
| Bimatoprost | 30 | 8.9 | 8.9 |
| Brimonidine Tartrate | 17 | 8.1 | 8.1 |
| Brinzolamide | 8 | 7.8 | 7.8 |
| Prednisolone Acetate | 9 | 7.3 | 7.4 |
| Timolol | 8 | 5.6 | 5.6 |
| Travoprost | 3 | 2.9 | 2.9 |